Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07016698 · ClinicalTrials.gov registry record · NA
Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)
A NA study of Peripheral Arterial Disease (PAD), sponsored by C. R. Bard.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 2
- Study locations
NCT07016698: Recruiting NA study of Peripheral Arterial Disease (PAD), sponsored by C. R. Bard.
NCT07016698 is a NA study of Peripheral Arterial Disease (PAD) that is actively recruiting participants, run by C. R. Bard. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07016698, a NA study of Peripheral Arterial Disease (PAD), is actively recruiting participants, sponsored by C. R. Bard.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
The XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.
Primary Outcome
Procedural Success defined as the rate of successful revascularization of target lesion (residual stenosis/thrombus ≤30%) following index procedure.
Conditions Studied
Interventions
- DEVICE Rotarex(TM) Rotational Excisional Atherectomy System
Study Locations (2)
Florida
- Radiology and Imaging Specialists - Lakeland
Texas
- Vital Heart and Vein - Humble
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-09-29 |
| Est. Completion | 2029-05-31 |
| Phase | NA |
What NCT07016698 shows while recruiting
NCT07016698 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Peripheral Arterial Disease (PAD) appearing as the primary indexed condition, and to 1 intervention - of which Rotarex(TM) Rotational Excisional Atherectomy System is the first listed.
NCT07016698 reports a single indexed study location in Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT07016698 about?
NCT07016698 is a clinical study titled "Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)". The XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.
What is the current status of trial NCT07016698?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-09-29. Estimated completion is 2029-05-31.
What conditions does trial NCT07016698 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease (PAD).
What interventions are being tested in trial NCT07016698?
The interventions under investigation include: Rotarex(TM) Rotational Excisional Atherectomy System (DEVICE).
Who is sponsoring clinical trial NCT07016698?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07016698 being conducted?
This trial has 2 study locations across Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease (PAD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07016698's enrollment target sits among peer trials
600 162nd of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI